http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2010123174-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-351 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7016 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-702 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-726 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35 |
filingDate | 2008-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2011-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2010123174-A |
titleOfInvention | PREVENTION AND TREATMENT OF SECONDARY INFECTIONS AFTER VIRAL INFECTION |
abstract | 1. A synthetic nutritional composition suitable for use in the prevention of secondary infections after a viral infection characterized by neuraminidase activity, including sialylated oligosaccharide and N-acetylactosamine and / or oligosaccharide containing N-acetylactosamine. ! 2. The composition according to claim 1, where the sialylated oligosaccharide is selected from the group comprising 3 'sialyllactose and 6' sialyllactose. ! 3. The composition according to claim 2, which includes 3 'sialyllactose and 6' sialyllactose. ! 4. The composition according to claim 3, where the ratio between 3 'sialyllactose and 6' sialyllactose is between 5: 1 and 1: 2. ! 5. The composition according to claim 1, where the oligosaccharide containing N-acetylactosamine is selected from the group comprising N-tetraose and lacto-N-neotetraose. ! 6. The composition according to claim 1, which further includes a probiotic bacterial strain. ! 7. The composition according to claim 1, which is a milk mixture, a subsequent mixture or milk for an older age. ! 8. The composition according to claim 7, which includes from 0.05 to 2 g of sialylated oligosaccharide / 100 g of the composition. ! 9. The composition according to claim 7 or 8, which includes from 0.1 to 3 g of N-acetylactosamine and / or oligosaccharide containing N-acetylactosamine / 100 g of the composition. ! 10. The composition according to claim 1, which further includes at least one prebiotic in an amount of from 0.3 to 10 wt.% Of the composition. ! 11. The composition according to claim 1, which is an additive and which includes from 0.1 to 2 g of sialylated oligosaccharide and 0.1-3 g of N-acetylactosamine and / or oligosaccharide containing N-acetylactosamine per single dose. ! 12. The use of a composition according to claim 1 for the manufacture of a medicament or therapeutic nutritional composition for the prevention of Tue |
priorityDate | 2007-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 187.